Floatz logo

Rifaximin

Heart Failure with Preserved Ejection Fraction

I.M. Sechenov First Moscow State Medical UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

17 Active assets in the Heart Failure with Preserved Ejection Fraction cohort.

Asset / SponsorPhaseRating
Tirzepatide
Yunlong Wang
Phase 4BBB
Semaglutide
Mayo Clinic
Phase 4BBB
Metformin
Sara ElAdawy
Phase 4BBB
Liraglutide
Leiden University Medical Center
Phase 4BBB
Tadalafil
Kafrelsheikh University
Phase 4BB

View all 23 →

Same molecule, other indications

Rifaximin is also rated in:

hepatic encephalopathyDormant
BBB
Indicative ·
75 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →
AscitesDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →